Trial intelligence / Profile preview

Simethicone Emulsion Before Esophagogastroduodenoscopy

ChiCTR-IPR-16008080Phase 4Recruiting

Sponsor
Changhai Hospital
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of simethicone in gastric cancer (GC), Peptic ulcer disease (PUD), Gastric polyps and 1 more (2 arms), sponsored by Changhai Hospital. Primary endpoint: Upper gastrointestinal endoscopy view definition. Started Mar 2016; status: recruiting.

02

Drugs

simethicone
03

Conditions

gastric cancer (GC)Peptic ulcer disease (PUD)Gastric polypsupper gastrointestinal bleeding (UGIB)

Beyond the preview

Go deeper on ChiCTR-IPR-16008080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16008080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call